| An integrated tumor, immune and microbiome atlas of colon cancer J Roelands, PJK Kuppen, EI Ahmed, R Mall, T Masoodi, P Singh, ... Nature medicine 29 (5), 1273-1286, 2023 | 78 | 2023 |
| A population study of clinically actionable genetic variation affecting drug response from the Middle East PV Jithesh, M Abuhaliqa, N Syed, I Ahmed, M El Anbari, K Bastaki, ... NPJ genomic medicine 7 (1), 10, 2022 | 30 | 2022 |
| The immune landscape of solid pediatric tumors S Sherif, J Roelands, W Mifsud, EI Ahmed, CM Raynaud, D Rinchai, ... Journal of Experimental & Clinical Cancer Research 41 (1), 199, 2022 | 25 | 2022 |
| Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting S Sherif, R Mall, H Almeer, A Naik, A Al Homaid, R Thomas, J Roelands, ... Journal of Translational Medicine 20 (1), 442, 2022 | 9 | 2022 |
| A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer M Mason, Ó Lapuente-Santana, AS Halkola, W Wang, R Mall, X Xiao, ... Journal of translational medicine 22 (1), 190, 2024 | 6 | 2024 |
| Positive regulation of oxidative phosphorylation by nuclear myosin 1 protects cells from metabolic reprogramming and tumorigenesis in mice T Venit, O Sapkota, WS Abdrabou, P Loganathan, R Pasricha, ... Nature communications 14 (1), 6328, 2023 | 6 | 2023 |
| Modulation of SLFN11 induces changes in DNA Damage response in breast cancer CM Raynaud, EI Ahmed, A Jabeen, A Sanchez, S Sherif, ... Cancer Cell International 23 (1), 291, 2023 | 3 | 2023 |
| Modulation of SLFN11 induces changes in DNA Damage response CM Raynaud, EI Ahmed, A Jabeen, A Sanchez, S Sherif, TC Lobo, ... bioRxiv, 2023.04. 02.535254, 2023 | 1 | 2023 |
| The Immune landscape of pediatric solid tumors S Sherif, J Roelands, W Mifsud, E Ahmed, B Mifsud, D Bedognetti, ... bioRxiv, 2021.05. 04.442503, 2021 | 1 | 2021 |
| 5-AZA treatment induces cytotoxicity and in vitro expression of immunogenic NY-ESO-1 antigen in non-small lung cancer cell NCI-H1975 VP Inchakalody, S Taleb, S Sherif, Q Fernandes, F Sahir, SK Sivaraman, ... Annals of Oncology 30, xi14-xi15, 2019 | 1 | 2019 |
| Upregulation of interferon signaling predicts sustained complete remission in pediatric AML patients C Cugno, S Sherif, A Ali, D Rinchai, M Elanbari, D Kizhakayil, M Toufiq, ... | | 2024 |
| MUC2 Expression Modulates Immune Infiltration in Colorectal Cancer CM Raynaud, A Jabeen, EI Ahmed, S Hubrack, A Sanchez, S Sherif, ... bioRxiv, 2024.08. 06.594842, 2024 | | 2024 |
| Identification of an unusual combination of actionable mutations through genomic profiling in a child with an aggressive sarcoma. S Sherif, WRL Hendrickx, C Raynaud, W Mifsud, D Bedognetti, A Maaz | | 2023 |
| Immune–microbiota interactions affect the prognosis of patients with colon cancer Nature Medicine, 2023 | | 2023 |
| Author Correction: Positive regulation of oxidative phosphorylation by nuclear myosin 1 protects cells from metabolic reprogramming and tumorigenesis in mice T Venit, O Sapkota, WS Abdrabou, P Loganathan, R Pasricha, ... nature communications 14, 2023 | | 2023 |
| 15P Serum immune checkpoint biomarkers as predictors of response to anti-PD-1/PD-L1 treatment in non-small cell lung cancer (NSCLC) patients A Raza, R Mohsin, A Kanbour, S Vijayakar, A Philip, MA Tauro, S Sherif, ... Annals of Oncology 32, S1380, 2021 | | 2021 |
| 520 The immune landscape of pediatric tumors S Sherif, J Roelands, W Mifsud, B Dason, D Rinchai, A Charles, A Saleh, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
